ArticleOncotarget2013

Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib.

Raya Faigenbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.